Viva Biotech Holdings (VBIZF)
USD 0.11
(0.0%)
USD 0.11
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.15 Billion | 2.37 Billion | 2.1 Billion | 696.95 Million | 323.05 Million | 210.03 Million |
| Cost of Revenue | 1.41 Billion | 1.56 Billion | 1.45 Billion | 392.09 Million | 167.18 Million | 104.57 Million |
| Gross Profit | 738.43 Million | 815.67 Million | 650.98 Million | 304.86 Million | 155.87 Million | 105.45 Million |
| Operating Expenses | 545.74 Million | 502.23 Million | 378.66 Million | 179.85 Million | 111.86 Million | 75.21 Million |
| Selling, General and Administrative Expenses | 417.78 Million | 404.45 Million | 320.28 Million | 123.25 Million | 72.69 Million | 53.77 Million |
| Research and Development Expenses | 127.96 Million | 135.83 Million | 92.38 Million | 66.04 Million | 44.95 Million | 25.25 Million |
| Other Expenses | - | -1.44 Million | 125.27 Million | -582.56 Million | -34.2 Million | -20.61 Million |
| Cost and Expenses | 1.96 Billion | 2.06 Billion | 1.83 Billion | 571.94 Million | 279.04 Million | 179.79 Million |
| Operating Income | 192.68 Million | 187.21 Million | 455.57 Million | -441.32 Million | 55.71 Million | 21.87 Million |
| Interest Expense | 176.58 Million | 184.67 Million | 183.1 Million | 62.13 Million | 2.26 Million | 557 Thousand |
| Income Tax Expense | 43.83 Million | 45.05 Million | 47.14 Million | 22.66 Million | 15.05 Million | 15.31 Million |
| Earnings before Tax | -55.95 Million | -459.16 Million | 347.7 Million | -356.21 Million | 280.92 Million | 105.86 Million |
| Net Income | -116.11 Million | -528.47 Million | 287.54 Million | -386.88 Million | 265.87 Million | 90.55 Million |
| Earnings Per Share Basic | -0.14 | -0.28 | 0.15 | -0.25 | 0.19 | 0.06 |
| Earnings Per Share Diluted | -0.06 | -0.28 | 0.08 | -0.25 | 0.18 | 0.06 |
| Weighted Average Shares Outstanding | 811.04 Million | 1.91 Billion | 1.91 Billion | 1.57 Billion | 1.48 Billion | 1.5 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.02 Billion | 1.91 Billion | 1.97 Billion | 1.57 Billion | 1.48 Billion | 1.5 Billion |
| Gross Margin | 0.34 | 0.34 | 0.31 | 0.44 | 0.48 | 0.50 |
| EBIT Margin | 0.18 | 0.16 | 0.29 | -0.53 | 0.28 | 0.15 |
| Profit Margin | -0.05 | -0.22 | 0.14 | -0.56 | 0.82 | 0.43 |
| EBITDA | 391.01 Million | 372.66 Million | 683.96 Million | -223.89 Million | 317.23 Million | 31.42 Million |
| Earnings Before Tax Margin | 0.09 | 0.08 | 0.22 | -0.63 | 0.17 | 0.10 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 67.54 Million | 67.98 Million | 140.16 Million | 2.15 Billion | 69.4 Million | 164.78 Million |
| Cost of Revenue | 44.21 Million | 44.5 Million | 94.18 Million | 1.41 Billion | 46.63 Million | 106.21 Million |
| Gross Profit | 23.33 Million | 23.48 Million | 45.98 Million | 738.43 Million | 22.76 Million | 58.57 Million |
| Operating Expenses | 14.97 Million | 15.06 Million | 36.6 Million | 482.3 Million | 24.01 Million | 40.55 Million |
| Selling, General and Administrative Expenses | 12.02 Million | 12.1 Million | 29.51 Million | - | 14.65 Million | 29.48 Million |
| Research and Development Expenses | 2.94 Million | 2.96 Million | 7.09 Million | - | 3.51 Million | 11.06 Million |
| Other Expenses | - | - | - | 164.27 Million | - | - |
| Cost and Expenses | 59.18 Million | 59.57 Million | 130.78 Million | 1.89 Billion | 70.64 Million | 146.77 Million |
| Operating Income | 8.36 Million | 8.41 Million | 9.37 Million | 192.68 Million | 4.64 Million | 18.01 Million |
| Interest Expense | 4.49 Million | - | 12.47 Million | 176.58 Million | - | 12.94 Million |
| Income Tax Expense | 2.84 Million | 2.85 Million | 2.86 Million | 43.83 Million | 1.42 Million | 3.33 Million |
| Earnings before Tax | 12.76 Million | 12.84 Million | -12.82 Million | -55.95 Million | -6.34 Million | 5.3 Million |
| Net Income | 8.03 Million | 8.08 Million | -16.2 Million | -116.11 Million | -8.02 Million | 146.15 Thousand |
| Earnings Per Share Basic | 0.00 | 0.00 | -0.01 | - | -0.01 | 0.00 |
| Earnings Per Share Diluted | 0.00 | 0.00 | -0.01 | - | -0.00 | 0.00 |
| Weighted Average Shares Outstanding | 2.33 Billion | 2.33 Billion | 1.91 Billion | 1.94 Billion | 857.53 Million | 1.91 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.14 Billion | 2.14 Billion | 1.91 Billion | 2.02 Billion | 1.96 Billion | 1.91 Billion |
| Gross Margin | 0.35 | 0.35 | 0.33 | 0.34 | 0.33 | 0.36 |
| EBIT Margin | 0.22 | 0.22 | 0.17 | - | 0.16 | 0.20 |
| Profit Margin | 0.12 | 0.12 | -0.12 | -0.05 | -0.12 | 0.00 |
| EBITDA | 14.82 Million | 14.92 Million | 23.96 Million | - | 11.15 Million | 33.27 Million |
| Earnings Before Tax Margin | 0.12 | 0.12 | 0.07 | 0.09 | 0.07 | 0.11 |
1183
1867
3024
NFN
PLBY
3018